Virpax Pharmaceuticals (VRPX) Stock Chart & Stock Price History $0.23 -0.01 (-2.72%) As of 03:19 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Virpax Pharmaceuticals Stock Price Performance The Virpax Pharmaceuticals (VRPX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 98.68%, with a year-to-date return of -97.56%. In the past month, the stock has decreased 14.29%, reflecting recent market activity. As of the latest close, Virpax Pharmaceuticals traded at $0.24 with a market cap of $296 thousand and volume of 3,690 shares. Receive VRPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-5.07%1 Month Performance-14.29%3 Month Performance-94.78%Year-To-Date Performance-97.56%1 Year Performance-98.68% VRPX Stock Chart for Friday, June, 13, 2025 VRPX Chart by TradingView Virpax Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$0.24$0.23-2.72%$0.25$0.23782 shs$288,000.0006/12/2025$0.26$0.24-8.27%$0.28$0.233,690 shs$296,000.0006/11/2025$0.26$0.26+0.04%$0.28$0.2666,023 shs$323,000.0006/10/2025$0.24$0.26+8.33%$0.26$0.243,622 shs$323,000.0006/09/2025$0.24$0.24-1.84%$0.26$0.242,107 shs$298,000.0006/06/2025$0.24$0.24+1.79%$0.27$0.2412,599 shs$304,000.0006/05/2025$0.25$0.24-4.07%$0.27$0.247,564 shs$298,000.0006/04/2025$0.28$0.25-9.93%$0.27$0.246,338 shs$311,000.0006/03/2025$0.25$0.28+13.47%$0.28$0.2315,590 shs$345,000.0006/02/2025$0.25$0.25-0.20%$0.28$0.243,582 shs$304,000.00 Get the Latest News and Ratings for VRPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$0.24$0.25+4.25%$0.25$0.243,085 shs$305,000.0005/29/2025$0.23$0.24+1.95%$0.28$0.218,824 shs$292,000.0005/28/2025$0.24$0.23-3.79%$0.29$0.215,876 shs$287,000.0005/27/2025$0.23$0.24+4.39%$0.25$0.241,460 shs$298,000.0005/26/2025$0.23$0.23$0.26$0.2224,302 shs$286,000.0005/23/2025$0.22$0.23+3.60%$0.26$0.2224,302 shs$286,000.0005/22/2025$0.22$0.22+3.26%$0.25$0.2228,590 shs$276,000.0005/21/2025$0.22$0.22-2.27%$0.23$0.2117,746 shs$267,000.0005/20/2025$0.22$0.22$0.22$0.221,328 shs$273,000.0005/19/2025$0.23$0.22-5.17%$0.23$0.217,300 shs$273,000.0005/16/2025$0.24$0.23-4.13%$0.30$0.2115,308 shs$288,000.0005/15/2025$0.24$0.24+0.83%$0.26$0.2416,679 shs$301,000.0005/14/2025$0.27$0.24-11.37%$0.27$0.234,191 shs$298,000.0005/13/2025$0.25$0.27+10.53%$0.27$0.2311,483 shs$336,000.0005/12/2025$0.24$0.25+0.82%$0.29$0.2312,054 shs$304,000.00 Related Companies CWBR Stock Price Chart EVFM Stock Price Chart TRVN Stock Price Chart PTPI Stock Price Chart NMTR Stock Price Chart SYRS Stock Price Chart REVB Stock Price Chart SRNE Stock Price Chart ATXI Stock Price Chart BIOR Stock Price Chart Receive VRPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRPX) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virpax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRPX Stock Free VRPX Stock Alerts